BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
31 results:

  • 1. Ki-67 Change in Anthracyline-containing Neoadjuvant Chemotherapy Response in breast cancer.
    Yang ZG; Ren LH; Wang F; Wang PL; Wang WY; Lin SY
    Curr Med Sci; 2024 Feb; 44(1):156-167. PubMed ID: 38302780
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Association between ER, PR, HER2, and ER-/PR+ Expression and Lung cancer Subsequent in breast cancer Patients: A Retrospective Cohort Study Based on SEER Database.
    Shao HY; Hao BT; Gao FX
    Breast J; 2023; 2023():7028189. PubMed ID: 38021219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.
    Liu S; Hu Q; Xie Z; Chen S; Li Y; Quan N; Huang K; Li R; Fang L
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15589-15608. PubMed ID: 37653101
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients.
    Chen Z; Jia H; Zhang H; Chen L; Zhao P; Zhao J; Fu G; Xing X; Li Y; Wang C
    Breast Cancer Res Treat; 2023 Nov; 202(2):313-323. PubMed ID: 37639064
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
    Althobiti M; El-Sharawy KA; Joseph C; Aleskandarany M; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Oct; 189(3):621-630. PubMed ID: 34453638
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.
    Wang G; Zhang S; Wang M; Liu L; Liu Y; Tang L; Bai H; Zhao H
    BMC Cancer; 2021 Jul; 21(1):875. PubMed ID: 34330233
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis.
    Li Y; Zhao X; Liu Q; Liu Y
    Ann Med; 2021 Dec; 53(1):1019-1031. PubMed ID: 34187256
    [No Abstract]    [Full Text] [Related]  

  • 8. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
    Boerner T; Drill E; Pak LM; Nguyen B; Sigel CS; Doussot A; Shin P; Goldman DA; Gonen M; Allen PJ; Balachandran VP; Cercek A; Harding J; Solit DB; Schultz N; Kundra R; Walch H; D'Angelica MI; DeMatteo RP; Drebin J; Kemeny NE; Kingham TP; Simpson AL; Hechtman JF; Vakiani E; Lowery MA; Ijzermans JNM; Buettner S; Koerkamp BG; Doukas M; Chandwani R; Jarnagin WR
    Hepatology; 2021 Sep; 74(3):1429-1444. PubMed ID: 33765338
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
    Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
    J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis.
    Liu M; Xie F; Liu M; Zhang Y; Wang S
    Breast Cancer Res Treat; 2021 Apr; 186(3):591-605. PubMed ID: 33559780
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor prognosis in breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
    Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
    Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
    Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
    Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer.
    Johnstone CN; Pattison AD; Gorringe KL; Harrison PF; Powell DR; Lock P; Baloyan D; Ernst M; Stewart AG; Beilharz TH; Anderson RL
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29720474
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early breast cancer: Results From the ADEBAR Study.
    Mutschler NS; Scholz C; Friedl TWP; Zwingers T; Fasching PA; Beckmann MW; Fehm T; Mohrmann S; Salmen J; Ziegler C; Jäger B; Widschwendter P; de Gregorio N; Schochter F; Mahner S; Harbeck N; Weissenbacher T; Jückstock J; Janni W; Rack B
    Clin Breast Cancer; 2018 Apr; 18(2):175-183. PubMed ID: 29598955
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience.
    Houzé de l'Aulnoit A; Rogoz B; Pinçon C; Houzé de l'Aulnoit D
    Breast; 2018 Feb; 37():80-88. PubMed ID: 29102782
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Lechien JR; Nassri A; Kindt N; Brown DN; Journe F; Saussez S
    Head Neck; 2017 Dec; 39(12):2573-2584. PubMed ID: 28963807
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long-term outcome in young women with breast cancer: a population-based study.
    Fredholm H; Magnusson K; Lindström LS; Garmo H; Fält SE; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I
    Breast Cancer Res Treat; 2016 Nov; 160(1):131-143. PubMed ID: 27624330
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.